About this trial
Protein-rich foods may improve brain insulin-sensitivity, which is important for cognitive and metabolic health, and may also translate into an improved food intake regulation. It is therefore pertinent to delineate the effects of plant-derived proteins, which are a more sustainable alternative to animal-derived proteins, on brain insulin-sensitivity and related functional benefits. The hypothesis is that daily plant-derived or animal-derived protein supplementation improves brain vascular function and insulin-sensitivity, thereby improving cognitive performance and appetite control in overweight or obese older men and women.
The primary objective is to investigate in overweight or obese older adults the effect of daily protein supplementation for two weeks with either a plant-derived protein or an animal-derived protein on vascular function and insulin-sensitivity in the brain, while changes in cognitive performance and appetite-related brain reward activity will also be evaluated (secondary study objectives). Cerebral blood flow responses before (brain vascular function) and after the administration of intranasal insulin spray (brain insulin-sensitivity) will be quantified by the gold standard magnetic resonance imaging (MRI)-perfusion method Arterial Spin Labeling (ASL).
Eligibility criteria
Qualifiers
Men and women, aged between 60-75 years (older adults)
BMI between 25-35 kg/m2 (overweight or obese)
Fasting plasma glucose < 7.0 mmol/L
Fasting serum total cholesterol < 8.0 mmol/L
Disqualifiers
Intolerant to milk products or fava bean allergy
Vegetarians
Left-handedness
Current smoker, or smoking cessation < 12 months
Trial design
Treatments tested in this trial
- Protein supplementation with an animal-based protein isolate
- Protein supplementation with a plant-based protein isolate
- Control arm - cornstarch
Treatment groups
Sponsors and collaborators
Maastricht University Medical Center
Lead sponsor
Cosun
Collaborator